BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GC Biopharma Receives WHO Pre-Qualification for BARYCELA

WHO prequalification decision has made BARYCELA now eligible for procurement by the United Nations agencies, including the Pan American Health Organization...

February 20, 2023 | News

Lunit to Establish Subsidiary in Europe to Accelerate Business Expansion

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer solutions, today announced its decision to establish a new subsidiary, Lunit Europe Holdings,...

February 18, 2023 | News

HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities

HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders Interon is deve...

February 13, 2023 | News

Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy

This demonstrates the urgent unmet medical needs for Nefecon, as Everest also received Priority Review status for the New Drug Application (NDA) of Nefecon...

February 10, 2023 | News

GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea

This plant is the largest filling and finish facility based in South Korea, established in 2019. GC Biopharma installed an isolator facilities and app...

February 09, 2023 | News

SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

The additional investment for the ‘R&PD Center’ was confirmed by the board of directors committee with a total of 261 million USD SK bio...

February 08, 2023 | News

HeartSciences Announces Further Internationalization of its Patent Portfolio

Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical te...

February 06, 2023 | News

SK bioscience Receives Upgrade MSCI ESG Rating

According to the rating report, SK bioscience was recognized for its human resources development in the social(S) category and transparency of the board of...

February 03, 2023 | News

Lunit's AI solution is the first application tool that enhance Guardant Health's portfolio of cancer tests

Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit...

February 02, 2023 | News

SK bioscience’s World First Cell Culture-Based Influenza Vaccine Is Approved in Chile

The world first cell culture-based influenza vaccine, ‘SKYCellflu™’ is approved for the first time in South America SKYCellflu&t...

February 02, 2023 | News

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

SK bioscience shared a development history of the South Korea’s first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBM...

January 27, 2023 | News

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe Through this contr...

January 26, 2023 | News

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

This collaboration will utilize GenKOre's proprietary CRISPR-Cas platform, TaRGET (Tiny nuclease, augment RNA-...

January 26, 2023 | News

Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer

Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...

January 23, 2023 | News

Stay Connected